Indonesia has been awarded with an achievement award from the US Agency for International Development (USAID)’s Global Health unit for its successful campaign in tuberculosis management, amid growing success fighting the disease throughout Southeast Asia.

The guide offers clear, practical advice on how to manage the patients who have multidrug-resistant tuberculosis.

TB Alliance, an international non-profit organization which develops better, faster-acting, and affordable TB drugs, has announced that it has granted a license to and is working with the Open Source Drug Discovery (OSDD) programme of Council of Scientific and Industrial Research (CSIR) to develop and commercialize a promising new tuberculosis (TB) regimen for use within India. CSIR is an Indian governmental institution, which provides scientific and industrial R&D that maximizes the economic, environmental, and societal benefits for the people of India.

World TB Day is a good time to take stock of progress in global TB control. Unfortunately, TB continues to be major public health threat, with an estimated 8.7 million new cases per year, and an estimated 1.4 million deaths from TB. Early case detection and rapid treatment continues to remain the cornerstone of TB control strategy. With the incidence of TB declining very slowly, it is now obvious that TB cannot be eliminated by 2050.

1000 days to achieve international targets of 50% reductions in TB mortality and TB/HIV deaths by 2015

A new two-drug combination of rifapentine and moxifloxacin can allow tuberculosis treatment to be taken once-weekly during the four-month continuation phase.

Research and access required to achieve zero deaths, new infections, and suffering

GENEVA, 24 March 2013—Every day more than 1000 people living with HIV die of tuberculosis. This is unacceptable. Today we have the knowledge and the power to stop HIV and TB in their tracks. By integrating HIV and TB services and systems, we can save millions of lives and millions of dollars.

Health Ministers from several African countries and leaders of international agencies are meeting in Swaziland tomorrow where they will launch a fresh offensive against tuberculosis and TB among people with HIV.

Open letter to the European Medicines Agency regarding the filing of the drugs delamanid and bedaquiline for market approval.